Cargando…

Acute and long‐term efficacy of ablation index‐guided higher power shorter duration ablation in patients with atrial fibrillation: A prospective registry

BACKGROUND: Theoretically, targeting the same ablation index (AI) using higher power may achieve the same lesion size with a shorter ablation time. We evaluated the acute and long‐term efficacy of higher‐powered ablation guided by ablation index (HPAI) compared with conventional‐powered ablation gui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, So‐Ryoung, Park, Hyoung‐Seob, Choi, Eue‐Keun, Lee, Euijae, Oh, Seil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485805/ https://www.ncbi.nlm.nih.gov/pubmed/34621423 http://dx.doi.org/10.1002/joa3.12605

Ejemplares similares

Entrapment of a steerable diagnostic electrophysiologic catheter in the Thebesian valve during radiofrequency catheter ablation for atrial fibrillation
por: Lee, Euijae, et al.
Publicado: (2020)

Catheter ablation and thoracoscopic ablation in long persistent atrial fibrillation with large left atrium
por: Park, Chan Soon, et al.
Publicado: (2022)

Zero‐fluoroscopy catheter ablation for atrial fibrillation: a transitional period experience
por: Cha, Myung‐Jin, et al.
Publicado: (2020)

Virtual Ablation of Atrial Fibrillation in Patients With Persistent Atrial Fibrillation: An Unexplored Niche
por: Choi, Eue-Keun
Publicado: (2022)

Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis
por: Liu, Xing, et al.
Publicado: (2021)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
por: Moon, Inki, et al.
Publicado: (2019)

High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Efficacy and Safety of High-Power Short-Duration Radiofrequency Catheter Ablation of Atrial Fibrillation
por: Park, Je-Wook, et al.
Publicado: (2021)

Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study
por: Lee, Euijae, et al.
Publicado: (2018)

Low Lipid Levels and High Variability are Associated With the Risk of New‐Onset Atrial Fibrillation
por: Lee, Hyun‐Jung, et al.
Publicado: (2019)

A Genetic Risk Score for Atrial Fibrillation Predicts the Response to Catheter Ablation
por: Choe, Won-Seok, et al.
Publicado: (2018)

Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study
por: Lee, So-Ryoung, et al.
Publicado: (2020)

Prevalence of Non-valvular Atrial Fibrillation Based on Geographical Distribution and Socioeconomic Status in the Entire Korean Population
por: Lee, So-Ryoung, et al.
Publicado: (2018)

Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2019)

High‐power, short‐duration ablation during Box isolation for atrial fibrillation
por: Kumagai, Koichiro, et al.
Publicado: (2020)

Chromosomal abnormalities and atrial fibrillation and ischemic stroke incidence: a nationwide population-based study
por: Cho, Jun Hwan, et al.
Publicado: (2020)

High-power short-duration versus standard-power standard-duration settings for repeat atrial fibrillation ablation
por: Junarta, Joey, et al.
Publicado: (2021)

Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study
por: Kwon, Soonil, et al.
Publicado: (2019)

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2019)

Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Rhee, Tae-Min, et al.
Publicado: (2022)

Revisiting symptomatic pulmonary vein stenosis after high-power short-duration radiofrequency ablation in patients with atrial fibrillation
por: Kim, Joongmin, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study
por: Lee, So-Ryoung, et al.
Publicado: (2021)

Smoking Cessation after Diagnosis of New-Onset Atrial Fibrillation and the Risk of Stroke and Death
por: Lee, So-Ryoung, et al.
Publicado: (2021)

Lifestyle is associated with atrial fibrillation development in patients with type 2 diabetes mellitus
por: Park, Chan Soon, et al.
Publicado: (2021)

Ablation of Atrial Fibrillation in Patients with Hypertension—An Analysis from the German Ablation Registry
por: Zylla, Maura M., et al.
Publicado: (2020)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Impact of Hemoglobin Levels and Their Dynamic Changes on the Risk of Atrial Fibrillation: A Nationwide Population-Based Study
por: Lim, Woo-Hyun, et al.
Publicado: (2020)

Esophageal Endoscopy after High-power and Short-duration Ablation in Atrial Fibrillation Patients
por: Shin, Dong Geum, et al.
Publicado: (2020)

Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women
por: Rhee, Tae-Min, et al.
Publicado: (2022)

Impact of Socioeconomic Status on Emergency Department Visits in Patients With Atrial Fibrillation: A Nationwide Population‐Based Cohort Study
por: Lee, Seo‐Young, et al.
Publicado: (2022)

Machine Learning Prediction for the Recurrence After Electrical Cardioversion of Patients With Persistent Atrial Fibrillation
por: Kwon, Soonil, et al.
Publicado: (2023)

Validation of Adhesive Single-Lead ECG Device Compared with Holter Monitoring among Non-Atrial Fibrillation Patients
por: Kwon, Soonil, et al.
Publicado: (2021)

Comparative clinical outcomes of dronedarone and sotalol in Asian patients with atrial fibrillation: a nationwide cohort study
por: Lee, So-Ryoung, et al.
Publicado: (2020)

Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation
por: Khanra, Dibbendhu, et al.
Publicado: (2021)

Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population‐Based Study
por: Lee, Seo‐Young, et al.
Publicado: (2021)

Association between the accumulation of elevated serum γ-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study
por: Jeon, Won Kyeong, et al.
Publicado: (2023)

Efficiency, Safety, and Efficacy of High-Power Short-Duration Radiofrequency Ablation in Patients with Atrial Fibrillation
por: Sun, Xuerong, et al.
Publicado: (2021)

Ablation index-guided ablation with milder targets for atrial fibrillation: Comparison between high power and low power ablation
por: Liu, Zheng, et al.
Publicado: (2022)

Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry
por: Boersma, Lucas, et al.
Publicado: (2020)

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
por: Li, Yan-Guang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6c64nfdod003a3f0h6puta86ks